Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SKYSCRAPER-03: A Phase III, Open-Label, Randomized Study of Atezolizumab Plus Tiragolumab Compared With Durvalumab in Patients With Locally Advanced, Unresectable, Stage III NSCLC Who Have Not Progressed After Platinum-Based Concurrent Chemoradiation Dziadziuszko, R., Ahn, M. J., Kelly, K., Popat, S., Wakelee, H. A., Baird, A. M., Rooney, I., Afshari, M., Coleman, S., Zhang, Z., Kiruki, H., Patil, N., Wen, X., Bradley, J. D. ELSEVIER SCIENCE INC. 2021: E420-E421
View details for Web of Science ID 000715803800863